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Abstract
Background: Streptococcus suis is a zoonotic pathogen that causes invasive infections in humans and pigs. It has
been reported that S. suis infection in humans is mostly caused by serotype 2. However, human cases caused by
other serotypes have rarely been reported. This is the first report of a human case of infection with S. suis serotype
31 in Thailand.
Case presentation: A 55-year-old male alcohol misuser with liver cirrhosis was admitted with sepsis to a hospital in
the Central Region of Thailand. He had consumed a homemade, raw pork product prior to the onset of illness. He
was alive after treatment with ceftriaxone and no complication occurred. An isolate from blood culture at the hospital
was suspected as viridans group Streptococcus. It was confirmed at a reference laboratory as S. suis serotype 31 by
biochemical tests, 16S rDNA sequencing, and multiplex polymerase chain reaction for serotyping, but it was untypable
by the co-agglutination test with antisera against recognized S. suis serotypes, suggesting loss of capsular material. The
absence of a capsule was confirmed by transmission electron microscopy. The isolate was confirmed to be sequence
type 221, with 13 putative virulence genes that are usually found in serotype 2 strains.
Conclusion: We should be aware of the emergence of S. suis infections caused by uncommon serotypes in patients with
predisposing conditions. Laboratory capacity to identify S. suis in the hospital is needed in developing countries, which
can contribute to enhanced surveillance, epidemiological control, and prevention strategies in the prevalent area.
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Background
Streptococcus suis is a zoonotic pathogen that causes
invasive infections in humans who have been in close
contact with infected pigs or contaminated pork-derived
products, and this disease has lately received increasing
attention worldwide [1]. Of the 29 serotypes that have
been described, most of the clinical isolates from human
cases are serotype 2 strains [1]. However, human cases
caused by serotypes 1, 4, 5, 14, 16, 21 and 24, as well as
an untypable strain, have been reported; in particular,
serotypes 5, 14 and 24 and an uncapsulated strain have
been found in Thailand [1–3]. Serotypes other than
serotype 2 cause different clinical manifestations such as
septic arthritis and peritonitis caused by serotype 5,
meningitis by serotype 4 and 21, sepsis by serotype 24,
and peritonitis by serotype 16 [1]. The diversity of
infections caused by serotypes other than serotype 2 is
indicative of the awareness of diagnosticians of S. suis
infections [1].
Phenotypically, S. suis resembles the viridans streptococ-
cal species Streptococcus gordonii, Streptococcus sanguinis
and Streptococcus parasanguinis, and therefore may be
misidentified in many human diagnostic laboratories [4].
Therefore, molecular techniques as well as antiserum
serotyping are needed for confirmation of S. suis as well as
its serotype. We report here a case of sepsis caused by S.
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suis serotype 31 in a patient in Thailand, using a poly-
phasic approach to identify this bacterium, as well as the
results of genetic characterization of putative virulence
gene profile, capsule gene (cps) locus, and genetic related-
ness of S. suis serotype 31. The information from this
study may increase awareness of the emergence of S. suis
infections caused by uncommon strains, which will be
important in the development of surveillance systems and
epidemiological control and prevention strategies.
Case presentation
A 55-year-old man was admitted to a hospital in
Suphanburi Province, a central region in Thailand on
December 8, 2012. He had an underlying condition with
liver cirrhosis from a history of hepatitis B infection and
alcohol misuse. Before admission, he had a history of
raw pork product consumption (4 days prior to onset).
Physical examination revealed a temperature of 38.6 °C,
pulse rate of 102 beats/min, respiratory rate of 23
breaths/min, and blood pressure of 110/65 mmHg. No
nuchal stiffness, ecchymosis, or hearing loss was found.
Initial diagnosis in this case was sepsis based on systemic
inflammatory response syndrome [5]. His white blood
cell count was 13,600 cells/μL (70 % neutrophils) and
platelet count was 129,000/mm3. A comprehensive me-
tabolic panel revealed elevated creatinine level (1.95 mg/
dL), serum albumin level of 3.4 mg/dL, blood urea nitro-
gen (BUN) level of 18 mg/dL, serum aspartate ami-
notransferase (AST) level of 660 IU/L, serum alanine
aminotransferase (ALT) level of 130 IU/L, and creatine
phosphokinase (CPK) level of 740 U/L. A bacterial
isolate (no. 43640) was separated from the blood of the
patient and identified as viridans group Streptococcus
at the hospital laboratory. The isolate was sent to a
reference laboratory for confirmation of its species. It
was identified as S. suis by biochemical tests, multi-
plex polymerase chain reaction (PCR), and 16S rRNA
gene sequencing (99 % identity) [6–8]. Based on these
results, this case was finally diagnosed as sepsis. The
patient was treated with ceftriaxone and discharged
on December 14, 2012.
Multiplex PCR demonstrated that this isolate belonged
to serotype 31; however, antiserum serotyping revealed
that this strain did not agglutinate with the antisera of
any recognized S. suis serotypes [7, 9]. Further analysis
of this strain by transmission electron microscopy con-
firmed almost complete absence of capsular material
around the bacterial cells (Fig. 1) [10], showing the isolate
to be unencapsulated. The isolate was susceptible to peni-
cillin (MIC ≤0.12 μg/mL), ceftriaxone (MIC ≤1 μg/mL),
erythromycin (MIC ≤0.25 μg/mL), levofloxacin (MIC
≤2.0 μg/mL), clindamycin (MIC ≤0.25 μg/mL), and vanco-
mycin (MIC ≤1.0 μg/mL), and was resistant to tetracycline
(MIC ≥8.0 μg/mL). Since breakpoints for S. suis are not
defined in the 2014 Clinical and Laboratory Standards
Institute guidelines, breakpoints for the viridans group
streptococci were used instead.
Multilocus sequence typing (MLST) analysis of this
isolate showed that it belonged to sequence type (ST) 221
of clonal complex (CC) 221/234 (Fig. 2) [11]. PCR and se-
quencing were used to study the presence of 29 genes
previously associated with S. suis serotype 2 virulence.
These genes include the muramidase-released protein
gene (mrp), the extracellular factor gene (epf ), the suilysin
gene (sly), the arginine deaminase gene (arcA) [12], the
factor H-binding surface protein gene (fhb) [13], the
fibronectin-binding protein gene (fbps) [14], an infection-
related factor gene (trag) [15], the serum opacity factor
gene (ofs) [16], the S-ribosylhomocysteinase gene (luxS)
[17], the hyaluronate lyase gene (hyl) [18], the glutamine
synthetase gene (glnA) [19], an amylopullulanase gene
(apuA) [20], an enolase gene (eno) [21], an IgA protease
gene [22], the subtilisin-like protease gene (sspA) [23], the
sortase A gene (srtA) [24], the sortase BCD gene (srtBCD),
the sortase E gene (srtE), the sortase F gene (srtF), the
Fig. 1 Transmission electron micrographs of unencapsulated S. suis isolate no. 43640 (a), compared with an encapsulated strain (b). Scale bar = 0.5 μm
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sortase G gene (srtG) [25], the zinc uptake regulator gene
(zur) [26], the transcriptional regulator gene (rgg) [27],
orphan response regulator genes including covR and revS
[28, 29], the two-component regulatory system gene
(ciaRH) [30], the divalent-cation-related ABC trans-
porter genes (adcR and fur) [31], an iron-transporter
gene (feoB) [32], and the virulence-related gene (virA)
[33]. Our analysis of this isolate revealed the presence
of 13 genes found in virulent serotype 2 strains. The
IgA protease gene, arcA, luxS, glnA, apuA, eno, sspA,
srtA, covR, zur, fur, adcR and feoB were present in
this isolate; however, the well-recognized virulence
markers (epf/mrp/sly) were absent.
The entire cps locus of the unencapsulated serotype 31
strain 43640 (accession number KM576773) as well as
cpsA and cpsB of five encapsulated S. suis serotype 31
strains (p523, p346, p369, p567 and p559; accession num-
bers KM884773–KM884777) isolated from slaughtered
pigs were amplified and sequenced [see Additional file 1:
Table S1 and Additional file 2: Table S2]. Our isolate
showed an intact cpsA-cpsO (Fig. 3) as described for sero-
type 31 reference strain 92–4172 (accession number
AB737835). No insertions, deletions, or frameshifts were
found in the genes of the cps locus. In addition, the nu-
cleotide sequence of cpsA-cpsO in this isolate showed a
high identity (97 %) with the reference serotype 31. Com-
parison of the CpsA–CpsO protein sequences of both
strains also revealed high identities (97.75–100 %), except
for the CpsA and CpsB proteins, which had lower iden-
tities (93.11 and 84.71 %, respectively) with proteins of the
reference strain (Fig. 3).
Following the analysis of cpsA and cpsB, the CpsA pro-
tein of the unencapsulated strain 43640 was found to be
composed of 479 amino acids with the highest identity to
serotype 9-CpsA (96.66 %), followed by serotype 10-CpsA
(96.45 %) and serotype 24-CpsA (95.62 %) (Fig. 4). The
Fig. 2 An eBURST analysis of the entire S. suis MLST database (accessed on May 15, 2015). Clonal complexes relevant to human infection in Thailand
are circled and labeled. S. suis serotype 31 (ST221) in this study belonged to CC221/234 (bold circle). Clonal complexes and the predicted founders STs
are indicated by blue dots. The size of the dots is relative to the number of isolates with the respective ST present in the database
Fig. 3 Genetic organization of the cps locus in unencapsulated S. suis serotype 31 isolate no. 43640 and reference S. suis serotype 31 strain 92-4172.
Gray arrows indicate low similarity of amino acid sequences. Black arrows show high similarity of amino acid sequences
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CpsB protein sequence comprised 229 amino acids that
were identical to the reference serotype 31 as well as other
serotypes. The sequence presented a greater identity to
CpsB of the reference serotype 13 (91.27 %) and 24
(91.27 %) strains than to the reference serotype 31
(84.71 %) strain (Fig. 4). As shown in Fig. 4, the CpsA and
CpsB sequences of five additional encapsulated S. suis
serotype 31 strains isolated from pigs clustered with the
reference serotype 31 strain with a high percentage
identity (99–100 %), even though these sequences in
unencapsulated strain no. 43640 were distant.
Discussion
This is believed to be the first report of an unencapsu-
lated S. suis serotype 31 infection in humans. In general,
identification of S. suis as well as its serotypes can be
achieved with a polyphasic approach using biochemical
testing, antisera serotyping, and/or PCR assays [1]. As
mentioned above, human laboratories are less able to
identify this organism because of limited resources/tech-
nology, knowledge of S. suis, or phenotypic resemblance
between S. suis and the viridans streptococcal species or
others. Our study demonstrated that the hospital labora-
tory misidentified S. suis as viridians group Streptococ-
cus. Even though Thailand has a reference laboratory to
confirm unidentified bacteria from hospitals using a
polyphasic approach, laboratory capacity should be in-
creased, especially in hospital laboratories, to increase
their knowledge of S. suis identification.
The strain isolated from this case belonged to ST221
in CC221/234. To the best of our knowledge, only two
other unencapsulated strains have been recovered from
human cases [3, 34], although unencapsulated S. suis has
frequently been isolated from pigs [1, 35]. It is particularly
Fig. 4 Unrooted tree based on the alignments of CpsA (left) and CpsB (right) amino acid sequences in 33 serotypes of S. suis and our isolates
by a neighbor-joining method. Numbers at nodes represent bootstrap support expressed in percentages (1000 replications). Scale bar indicates
sequence dissimilarity
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interesting that CC221/234 did not contain any serotype 2
strains, but rather only serotype 24 strains (ST221 and
ST234) (http://ssuis.mlst.net/sql/burstspadvanced.asp). This
CC is not related to other CCs, especially the CCs
that are associated with human and pig infections,
such as CC1, CC16, CC20, CC25, CC27 and CC104
(Fig. 2) [1, 11, 36]. We have shown that CC221/234 S.
suis serotype 24 can cause sepsis, similar to the iso-
late in this study [2]. This suggests that CC221/234 is
a newly emerging, human infectious clone that does
not include serotype 2 strains.
Our isolate revealed the presence of 13 putative viru-
lence genes in virulent serotype 2 strains, as described
above. The presence of one or more of these genes may
have contributed to the virulence of this strain. Published
evidence indicates that mutations in one or more of these
putative virulence genes are sufficient to decrease the
virulence of S. suis. For example, ApuA promotes adhe-
sion to porcine epithelium and mucus in vitro [20]. The
subtilisin-like protease (sspA) and the IgA protease are
able to degrade natural proteins in host cells, for example
gelatins, fibrinogens, and IgA antibody [22, 23]. Enolase
plays an important role in adhesion to and invasion of
brain microvascular endothelial cells [21]. Aranda et al.
[32] demonstrated that full virulence of S. suis requires
the FeoB transporter. Inactivation of glnA in S. suis
resulted in reduced mortality and morbidity in murine
infection models [19]. In addition, inactivation of zur, covR
and luxS interferes with the expression of virulence fac-
tors, significantly contributing to attenuation of the viru-
lence of S. suis [17, 26, 28].
The present isolate caused sepsis with signs and symp-
toms that did not differ from those of infection with S.
suis serotype 2 strains. However, it is particularly inter-
esting that patients with infections caused by bacteria
other than serotype 2 also have predisposing conditions
such as cirrhosis, asplenia and splenectomy: a likely
explanation is that these infections are the result of
immunocompromise [1–3, 34, 37]. The fact that the
strain analyzed in this study was unencapsulated makes
it even more atypical. A previous study reported that
loss of the capsule may increase bacterial adhesion to
host cells, increase biofilm formation that may allow
bacteria to become persistent colonizers and to resist
clearance by the host immune system and antibiotics, as
well as induce the secretion of cytokines such as tumor
necrosis factor-α, interleukin (IL-1β, IL-6, and IL-8)
[10, 38–40]. Loss of the capsule may exacerbate the
immunological response induced by the exposed cell wall
components, leading to uncontrolled inflammatory reac-
tions that may promote the development of a severe dis-
ease outcome. Moreover, alcohol abuse and liver cirrhosis
may have contributed to the impaired neutrophil function
in this patient [41, 42]. These observations may explain
why the unencapsulated strain could survive in the blood
circulation and cause disease.
Three hypotheses have been established to explain the
unencapsulated phenotype. (1) Mutation in the promoter
region of the cps locus may contribute to unencapsulation.
Indeed, it has been shown that Staphylococcus aureus
strains with mutations in the promoter region upstream
of cap5(8)A fail to transcribe the capsule genes [43]. (2)
Some amino acid substitutions that are not due to non-
sense mutations and seem to result in an intact protein
may also contribute to unencapsulation [44]. That study
demonstrated that a single amino acid substitution each
in Cps2E and Cps2F was the main cause of the capsule
loss in S. suis serotype 2 or 1/2 isolates [44]. In the com-
parison between our isolate and reference serotype 31
strains, amino acid substitutions were found in the
CpsA–CpsO protein sequences; only CpsG and CpsJ
were found to have 100 % identity in their amino
acid sequences. CpsE and CpsF of this unencapsu-
lated strain revealed seven and one amino acid substi-
tutions, respectively. Other protein sequences had
substitutions in one position of CpsD, CpsH, CpsI,
CpsN and CpsO; two positions of CpsC; three posi-
tions of CpsI; five positions of CpsK and CpsM; and
nine positions of CpsL (data not shown). (3) S. suis
capsules are believed to be synthesized via the Wzx/
Wzy-dependent pathway, with a mature capsule trans-
located to the cell wall by the Wzd/Wze protein complex
encoded by cpsB and cpsC [45]. In our unencapsulated
strain, the cpsA and cpsB genes that encoded the CpsA
and CpsB proteins had low similarity to those of the refer-
ence serotype 31 strain (Figs. 3 and 4). We hypothesize
that dissimilar CpsB proteins may affect the compatibility
of the protein–protein interactions for capsule processing
in this unencapsulated strain. While CpsA is a capsule
expression regulator, it appears to modulate the transcrip-
tion of the capsule mRNA through specific binding to the
capsule gene promoter [46, 47]. The dissimilarity of this
protein in our isolate and in reference serotype 31 may
also result in reduced capsule expression. Incompatibility
of the protein–protein or protein–DNA interaction can-
not be ruled out.
Similar to our study, Liu et al. [48] reported that the
cps genes of S. suis strain YS54 were similar to reference
serotype 29 strain 92-1191, except for cpsH and cpsI.
The cpsH and cpsI of YS54 were similar to those of
reference serotype 21 strain 14A, while the cpsH and cpsI
of strain 14A shared no similarity with strain 91-1191
[48]. We speculated that horizontal gene transfer (HGT)
may have been involved in cpsA-cpsB replacement/switch-
ing in our case; however, we do not know the source of
the genes. HGT, via transformation, transduction or
conjugation, can lead to the acquisition of entirely new
sequences, as well as sequences that are homologous to
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existing DNA. The transfer of DNA via homologous
recombination leads to the replacement of a region of the
genome of a recipient cell by the corresponding region
from the donor cell [49]. HGT events are frequently ob-
served in Streptococcus such as Streptococcus pyogenes,
Streptococcus agalactiae and Streptococcus pneumoniae;
for example, genetic studies of S. pneumoniae serotype 6A
and 6C capsule gene loci showed that substitution of
wciN6C for wciN6A through homologous recombination
resulted in a serotype switch from 6A to 6C [50].
Conclusion
Although the isolation rate for this bacterial strain is still
low, the emergence of S. suis infections caused by un-
common serotypes as well as unencapsulated strains
should raise awareness in patients with predisposing
conditions. Increased laboratory capacity to identify S.
suis in hospitals is necessary in Thailand as well as in
developing countries to contribute towards enhanced
surveillance, epidemiological control, and prevention strat-
egies for public health. Further investigations, such as com-
plementation assay, should be considered to demonstrate
clearly the mechanisms of capsular loss in this particular
isolate [44].
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